8:00 – 8:30

Breakfast and Registration

8:30–8:35

Welcome

David L. Porter, MD, (Chair) University of Pennsylvania Health System, and Lauren Berger, MPH, The Leukemia & Lymphoma Society

8:35–8:45

LLS Impact: Advancing Cures

Gwen L. Nichols, MD, The Leukemia & Lymphoma Society

8:45–9:15

CAR T-cell Clinical Applications: Is It Right for My Patients?

Sergio A. Giralt, MD, Memorial Sloan Kettering Cancer Center

9:15–9:45

CAR T-cells for Acute Lymphoblastic Leukemia

Jamie L. Koprivnicar, MD, Hackensack University Medical Center   

9:45–10:15

CAR-T cells: A Major Advance for Patients with Refractory DLBCL 

Ira Braunschweig, MD, Montefiore Medical Center  

10:15 – 10:30

Break

10:30 – 11:00

CAR T-cells for Myeloma: The Next Major Disease Target?

Adam D. Cohen, MD, University of Pennsylvania Health System

11:00–11:30

CAR T-cells for Chronic Lymphocytic Leukemia

Jacqueline C. Barrientos, MD, MS, Northwell Health Cancer Institute, and Joanna Rhodes, MD, University of Pennsylvania Health System

11:30–12:00

CAR T Toxicity and Management

Ran Reshef, MD, MSc,  New York-Presbyterian, Columbia University Irving Medical Center

12:00 – 12:15

Q & A

David L. Porter, MD,  University of Pennsylvania Health System

12:15-12:30

12:30 – 1:15

Meet the Experts: 
Roundtable discussions facilitated by fellows and symposium faculty

Steven Bair, MD, University of Pennsylvania Health System                                                                 Susan Dewolf, MD, Memorial Sloan Kettering Cancer Center                                                                      Sukhdeep Kaur, MD, Rutgers Cancer Institute of New Jersey                                                                     Joanna M. Rhodes, MD, University of Pennsylvania Health System                                                                Larysa Sanchez, MD, Mount Sinai Medical Center    Catherine Wei, MD, Rutgers Cancer Institute of New Jersey  

1:15 – 2:15

Case Presentations  Non-Hodgkin Lymphoma and Myeloma: Referral, Treatment and Follow-up

Koen van Besien, MD, PhD, New York-Presbyterian, Weill Cornell Medicine and Deepu Madduri, MD, Mount Sinai Medical Center

2:15–2:45

CAR T-cells, Jump-starting Your Program

Dennis L. Cooper, MD, Rutgers Cancer Institute of New Jersey

2:45–3:15

Value, Cost & Reimbursement for CAR T Cells:  Overcoming the Obstacles

Gunjan L. Shah, MD, Memorial Sloan Kettering Cancer Center

3:15–4:00

It Takes a Village:  Panel Presentations & Discussion

Heather DiFilippo, MSN, CRNP, University of Pennsylvania Health System                                Nigina Mirazimova, MSN, RN, OCN® , New York Presbyterian/ Weill Cornell, New York, NY                 Mari Lynne Silverberg, MPA, RN, BSN, OCN®, Memorial Sloan Kettering Cancer Center         Elizabeth Weber, BSN, RN, University of Pennsylvania Health System

4:00–4:30

Interactive Panel Discussion and Q & A

David L. Porter, MD,  and panel